Kolistimetatnatrium Noridem

Colistimethate Sodium, the active ingredient in Kolistimetatnatrium Noridem, is a polymyxin antibiotic presented as a sterile powder for intracerebroventricular and intrathecal use. It is employed to treat serious Gram‑negative bacterial infections, including those affecting the central nervous system, in patients requiring direct cerebrospinal administration.

GNH USA supplies Kolistimetatnatrium Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kolistimetatnatrium Noridem, a polymyxin antibiotic, is indicated for infections caused by susceptible Gram‑negative organisms, particularly within the central nervous system. - Gram‑negative bacterial infections: eradicates susceptible strains resistant to other agents. - Central nervous system infections: delivers effective concentrations directly to cerebrospinal fluid for meningitis or ventriculitis. - Multidrug‑resistant infections: provides an option when alternative antibiotics are ineffective.

Colistimethate Sodium may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Neurotoxicity: dizziness, headache, paresthesia. - Nausea and vomiting. - Fever or chills. - Injection‑site pain or irritation. - Mild renal function changes. - Transient hypotension.

Serious or Rare Side Effects: - Acute renal failure. - Anaphylactic or severe allergic reactions. - Seizures or convulsions. - Respiratory distress. - Neuromuscular blockade leading to muscle weakness. - Meningitis from contaminated preparation.

When using Kolistimetatnatrium Noridem, clinicians should observe several safety measures. - Renal function monitoring: assess serum creatinine and urine output regularly. - Neurological assessment: watch for signs of neurotoxicity or altered mental status. - Avoid concomitant nephrotoxic agents: limit use with aminoglycosides or loop diuretics. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Dose adjustment in renal impairment: modify dosing based on estimated glomerular filtration rate. - Store at ambient temperature: keep in original pack, protect from moisture.

Colistimetatnatrium Noridem can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Aminoglycosides: additive nephrotoxicity. - Loop diuretics: increased risk of renal impairment. - Neuromuscular blocking agents: enhanced neuromuscular blockade. - Vancomycin: combined renal toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: may worsen renal function. - Corticosteroids: potential electrolyte disturbances. - Carbapenems: possible antagonistic antibacterial effect.